Announced Sun, 7 Sept · 10:39 IST

Submission of 31st Annual Report for the FY 2024-25

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

B2B Software Technologies has submitted its 31st Annual Report for FY 2024-25 to BSE under Regulation 34 of SEBI LODR. The 31st AGM is scheduled for Monday, September 29, 2025 at 10:30 AM IST via video conferencing, with e-voting open from September 26 to September 28, 2025 (cut-off date: September 22, 2025). Key AGM agenda items include: adoption of audited standalone and consolidated financial statements; re-appointment of Mrs. Parvatha Samantha Reddy as Director; appointment of M/s. M V Vijaya Kumar & Co. as new Statutory Auditors to fill the casual vacancy caused by the resignation of M/s Jawahar & Associates; approval of a material related party transaction with Antelope Valley Cancer Center (USA) owned by the company's Promoter and CEO Dr. Ram Chandra Rao Nemani, in collaboration with GeniusDoc; appointment of M/s DSMR and Associates as Secretarial Auditors for five years; ESOP grants (19,440 for FY24-25 and 5,371 for FY25-26) and a performance bonus of Rs. 20.87 lakh to Executive Director Mr. Bala Subramanyam Vanapalli; and appointment of Dr. Avinash Yaramati as Non-Executive Director.

Likely market impact

Routine annual compliance filing, but the AGM notice flags several matters shareholders should review carefully — particularly the related party transaction with a promoter-owned US clinic and the enhanced executive compensation package including ESOPs and a performance bonus exceeding standard limits.